Gene · 1
A1BG: alpha-1-B glycoprotein
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. A1BG: alpha-1-B glycoprotein. Genes, record 1. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/1
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P04217 | Alpha-1B-glycoprotein | 495 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents59
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 37146 | P04217 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 2167 | P04217 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 2 | P04217 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 5340 | P04217 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 5340 | P04217 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 2167 | P04217 | Espacenet |
| EP 4549945 A1 | 2025-05-07 | 1 | P04217 | Espacenet |
| US 12287342 B2 | 2025-04-29 | 2 | P04217 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 4286 | P04217 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 2 | P04217 | Espacenet |
1 to 10 of 59
See all 59 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,483
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | A1BG papers | Newest fiscal year |
|---|---|---|---|
| ZIADA000493 | Functional and Pharmacological Significance of Receptor Heteromers in the CNS | 6 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 5 | 2025 |
| ZIAHL006040 | Novel catheter treatment of structural heart and valve disease | 5 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 4 | 2025 |
| ZIANS003164 | Readout of the tubulin code by cellular effectors | 4 | 2025 |
| I01BX000740 | Right Heart Function in Health and Chronic Disease | 3 | 2025 |
| P30AI027757 | University of Washington/Fred Hutch Center for AIDS Research | 3 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 3 | 2025 |
| P30CA046934 | University of Colorado Cancer Center Support Grant | 3 | 2025 |
| R01GM073791 | Structural-Functional Basis of Actin Cytoskeleton Dynamics | 3 | 2025 |
1 to 10 of 1,483Source NIH's project files
See all 1,483 nih grantsPapers2,687
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Blood proteomics profiles are associated with progression of chronic kidney disease over 9 years: A prospective cohort study. | J Adv Res | 2026 | 42425452 | PubTator, text mining | PubMed |
| Proteomic and glycosylation biomarkers in rheumatoid arthritis: advancing early diagnosis and precision therapy. | Clin Proteomics | 2026 | 42402554 | PubTator, text mining | PubMed |
| The biological basis of Blood-Heat syndrome in children with Henoch-Schonlein purpura nephritis: a multidimensional analysis based on clinical proteomics and an animal model. | Front Pharmacol | 2026 | 42038305 | PubTator, text mining | PubMed |
| Integrative Multiomics Approaches Identify Biomarkers Associated With Progression From Arthralgia to Rheumatoid Arthritis. | Arthritis Rheumatol | 2026 | 42010917 | PubTator, text mining | PubMed |
| Salivary Proteomic Signatures Reveal Novel Mechanistic Insights into Moderate Dental Fluorosis Pathogenesis and Oral Homeostasis Disruption. | Comput Struct Biotechnol J | 2026 | 41971944 | PubTator, text mining | PubMed |
| Camouflaged object detection via context and texture-aware hierarchical interaction. | Sci Rep | 2026 | 41851168 | PubTator, text mining | PubMed |
| Serial Aqueous Humor Proteomics in Diabetic Macular Edema: Correlation of Novel Targets with Retinal Fluid Volume. | Ophthalmol Sci | 2026 | 41816091 | PubTator, text mining | PubMed |
| Adaptations in Plasmodium tubulin determine distinct microtubule architectures, mechanics and drug susceptibility. | Nat Commun | 2026 | 41786731 | PubTator, text mining | PubMed |
| The spleen-brain axis in Alzheimer's disease and related dementias: Integrating immune and metabolic regulation. | Alzheimers Dement | 2026 | 41778859 | PubTator, text mining | PubMed |
"Nothing for Us Without Us": A Mixed Methods Study Examining the Acceptability, Feasibility, and Impact of Involving Guardians of Children With Acute Lymphoblastic Leukemia in Tanzania as Public Contributors. | Cancer Med | 2026 | 41772304 | PubTator, text mining | PubMed |
1 to 10 of 2,687
See all 2,687 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/1
GET https://conductscience.org/api/genes/v1/1/patents?page=2